News MedMen Enterprises Inc.

Equities

MMEN

CA58507M1077

Delayed Canadian Securities Exchange Other stock markets 03:12:29 2024-01-05 pm EST			5-day change	1st Jan Change
0.015 ^CAD	-.--%		-25.00%	-25.00%

Jan. 24	MedMen Enterprises Brief: Furthermore, Michael Serruya, Executive Chairman, who has served on the Board since August 2021, has stepped down from the Board effective today	MT
Jan. 24	MedMen Enterprises Brief: Board has appointed Richard Ormond as Chief Restructuring Officer	MT

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

MedMen Enterprises Brief: Furthermore, Michael Serruya, Executive Chairman, who has served on the Board since August 2021, has stepped down from the Board effective today	Jan. 24	MT
MedMen Enterprises Brief: Board has appointed Richard Ormond as Chief Restructuring Officer	Jan. 24	MT
MedMen Enterprises Brief: Ellen Deutsch Harrison has stepped down as Chief Executive Officer and a Board member effective January 19, 2024	Jan. 24	MT
MedMen Announces Management and Board Changes	Jan. 24	BU
MedMen Enterprises Inc. Announces Management Changes	Jan. 24	CI
Ellen Deutsch Harrison Announces Step Down as Chief Executive Officer of MedMen Enterprises Inc	Jan. 24	CI
Canadian Investment Regulatory Organization Trading Halt - MMEN	Jan. 08	AQ
MedMen Exits Arizona Market, Completing Sale of Local Operations to MINT Cannabis	Jan. 05	BU
The Mint Cannabis completed the acquisition of Non-Core Business Operations in Arizona and Certain Assets in Nevada from MedMen Enterprises Inc..	Jan. 04	CI
MedMen Provides Annual Filing Status Report	Dec. 21	BU
MedMen Enterprises to Exit Arizona and Nevada, Selling Non-Core Assets to MINT Cannabis	Dec. 20	MT
MedMen Enters into Definitive Agreements to Exit Arizona and Nevada per Announced Strategic Review, Selling Non-Core Assets to MINT Cannabis	Dec. 20	BU
The Mint Cannabis entered into definitive agreements to acquire Non-Core Business Operations in Arizona and Certain Assets in Nevada from MedMen Enterprises Inc..	Dec. 19	CI
MedMen Provides Annual Filing Status Report	Nov. 30	BU
MedMen Provides Annual Filing Status Report	Nov. 16	BU
MedMen Announces Delay of Filing of Financial Statements for the Year Ended July 1, 2023 and Issuance of Management Cease Trade Order	Nov. 02	BU
Medmen Enterprises Inc. Appoints Melony Valleau as Its Chief Accounting Officer	23-10-02	CI
MedMen Enterprises : Management Change - Form 8-K	23-10-02	PU
MedMen Enterprises Brief: Deutsch has also been appointed to the Co's Board of Directors, increasing the size to six	23-07-05	MT
MedMen Enterprises Brief: Deutsch succeeds Interim CEO Edward Record, who will now continue as a non-executive member of MedMen's Board	23-07-05	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News MedMen Enterprises Inc.

Equities

MMEN

CA58507M1077

Summary

Filters